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doi:10.1Objectives: CyberKnife stereotactic body radiosurgery is a potentially curative option for medically inoperable
Stage I lung cancer. Fiducial marker placement in or near the tumor is required. Transthoracic placement using
computed tomography guidance has been associated with a high risk of iatrogenic pneumothorax. Electromag-
netic navigation bronchoscopy offers a safer method of placing markers; however, previous studies using linear
markers have shown at least a 10% dislocation rate. We describe the use of coil-spring fiducial markers placed
under moderate sedation in an outpatient bronchoscopy suite.
Methods: A total of 52 consecutive nonoperative patients with isolated lung tumors underwent fiducial place-
ment using electromagnetic navigation bronchoscopy. Of the 52 patients, 4 received 17 linear fiducial markers,
and 49 patients with 56 tumors received 217 coil-spring fiducial markers. The procedures were considered
successful if the fiducial markers had been placed in or near the tumors and had remained in place without
migration, allowing radiosurgery without the need for additional fiducial markers.
Results: A total of 234 fiducial markers were successfully deployed in 52 patients with 60 tumors (mean diam-
eter 23.7 mm). Of these 60 tumors, 35 (58%) were adjacent to the pleura. At CyberKnife planning, 8 (47%) of
17 linear fiducial markers and 215 (99%) of 217 coil-spring fiducial markers (P¼ .0001) were still in place. Of
the 4 patients with linear fiducial markers, 2 required additional fiducial placements; none of the patients with
coil fiducial markers required additional procedures. Three pneumothoraces (5.8%) occurred in peripheral
lesions (2 were treated with a pig-tail chest tube and 1 with observation only).
Conclusions: Deployment of coil spring fiducial markers using navigation bronchoscopy can safely be
performed with the patient under moderate sedation with almost no migration and a 5.8% rate of pneumothorax.
(J Thorac Cardiovasc Surg 2010;140:1137-42)Patients with lung cancer often have severe smoking-
induced morbidities such as chronic obstructive pulmonary
disease (COPD) and arteriosclerotic heart disease that
precludes a curative surgical approach. Stereotactic body ra-
diosurgery is a treatment option for patients who are unable
to undergo lung resection.1-5 For precise tumor ablation, the
CyberKnife (CyberKnife, Accuray Inc, Sunnyvale, Calif)
system requires fiducial marker placement in or near the
target tumor. Fiducial placement under transthoracic
computed tomography (CT) guidance is associated with
a high risk of iatrogenic pneumothorax development of
at least 13%.6 This rate is likely conservative becausee Division of Thoracic and Esophageal Surgery,a and the Pulmonary/Critical
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The Journal of Thoracic and CarCT-guided lung biopsy specimens have revealed pneumo-
thorax rates of 23% to 38%,7,8 and a recent study
reported a 48% pneumothorax rate with CT-guided fiducial
marker placement.9 Electromagnetic navigation bronchos-
copy (ENB) offers a less morbid alternative to accurately
guide bronchoscopic tools and deploy fiducial markers
within the bronchial tree to endoscopically invisible periph-
eral lung lesions. Previous studies, in which linear markers
were used, showed at least a 10% dislocation rate10,11 and
required general anesthesia for placement.11,12 In the
present study, we have proposed the use of coil-spring fidu-
cial markers deployed using ENB with the patient under
moderate sedation in an outpatient bronchoscopy suite.E
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A total of 52 consecutive patients who had been referred for broncho-
scopic fiducial marker placement were recruited between September
2008 and March 2010. All patients had peripheral lung tumors and no
CTevidence of endobronchial pathologic features. All cases were reviewed
at a multidisciplinary thoracic oncology board. Of the 52 patients, 47 had
been deemed inoperable and 5 had refused surgery. All patients underwent
positron emission tomography scanning, and if any activity was seen in the
mediastinum or hilum, the patients underwent either mediastinoscopy or
endobronchial ultrasonography to rule out extrapulmonary disease before
proceeding with stereotactic body radiosurgery. The institutional reviewdiovascular Surgery c Volume 140, Number 5 1137
Abbreviations and Acronyms
COPD ¼ chronic obstructive pulmonary disease
CT ¼ computed tomography
ENB ¼ electromagnetic navigation
bronchoscopy
SD ¼ standard deviation
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tion and analysis.
ENB Procedure
The superDimension inReach System (superDimension Inc, Plymouth,
Minn) was used for ENB. All patients underwent noncontrast-enhanced CT
scans of the chest with a slice thickness of 1 to 1.5 mm and a slice interval
of 1 to 2 mm, with an overlap of 1 mm. The initial planning phase required
importing Digital Imaging and Communications in Medicine format CD
data into the planning software. Using 3-dimensional reconstruction, an
endobronchial track to the tumor target lesion was mapped. The patient
was placed on an electromagnetic location board. Bronchoscopy was
performed with the patient under moderate sedation using the oral route
and an adult therapeutic bronchoscope (Olympus IT160; Olympus, Tokyo,
Japan) with a 2.8-mm working channel. The patient’s endobronchial ana-
tomic landmarks were registered in the magnetic field and overlayed
with the 3-dimensional reconstructed CT scan. An anatomic divergence
error of<5 mm was accepted. Navigation began by wedging the broncho-
scope in the suspected bronchial segment and steering the sensor probe and
the extended working channel to the tumor using the multiplanar CT scan
images and the ‘‘tip-view’’ orientation. The tumor was considered located
when a minimum distance (<1 cm) between the steerable probe tip and the
center of the lesion was achieved (Figure 1). When navigation was com-
pleted, the steerable probewas removed, and the extended working channel
sheath left in place. A transbronchial biopsy could be performed at this
point directly into the tumor.Fiducial Marker Placement
The initial 4 patients received linear gold fiducial markers (1 3 5 mm,
CyberMark MT-NW-887-853, Civco Medical Solutions, Orange City,
Iowa). The subsequent 56 fiducial marker placements used platinum coil
spring markers (diamond-shaped, 3 3 3.3 mm, VortX-18, Boston Scien-
tific, Cork, Ireland) (Figure 2). Both fiducial markers were delivered using
wax tip microbiology specimen brushes (catalogue no. 130; ConMed
Endoscopic Technologies, Chelmsford, Mass) (Figure 2, A) through the
extended working channel sheath under fluoroscopic control. The wax
plug was removed before loading the delivery brush with either fiducial
type and than temporarily sealed with viscose sterile lubricant. The
VortX-18 fiducial markers were loaded into the microbiology catheter by
way of injection from their delivery needle. After each fiducial placement,
the working channel sheath was navigated to a different area of the tumor
before the next marker was deployed. Ideally, the fiducial markers should
have a minimum spatial separation of 20 mm and a 3-dimensional angular
separation. Chest radiographs were obtained after the procedure to confirm
the fiducial position and to rule out any pneumothorax (Figure 3).
CyberKnife planning CT scans were performed 7 to 14 days after fidu-
cial marker placement and reviewed by a thoracic surgeon, radiation oncol-
ogist, and nuclear physicist to assess the adequacy of fiducial marker
placement. The need for alternative or additional intrathoracic fiducial
placement was documented as procedure failure.
Data collection, demographics, and basic statistical analysis were
performed on a personal computer using the Statistical Package for Social1138 The Journal of Thoracic and Cardiovascular SurSciences for Windows, version 13.0 (SPSS Inc, Chicago, Ill). The paramet-
ric data are presented as the in mean  standard deviation (SD). An asso-
ciation between categorical variables was tested using the 2-tailed Fisher
exact test.RESULTS
A total of 52 patients underwent 60 fiducial maker place-
ments. A total of 234 fiducial markers were successfully de-
ployed. The initial 4 patients had linear gold fiducial
markers placed. Of the 4 patients, 2 required additional
CT or bronchoscopy-guided fiducial placement. Only 8
(47%) of the 17 linear fiducial markers were still in place
at CyberKnife planning 1 to 2 weeks after placement.
This led us to change the type of fiducial markers to coil
spring platinum markers that promised better anchorage
within the lung tissue because of their self-expandingmech-
anism and thrombogenic filament attachments (Figure 2,
B). Of the 217 coil-spring fiducial markers, 215 (99%)
were still in place at CyberKnife planning, a significant
improvement compared with the linear fiducial type
(P ¼ .0001). All the coil spring fiducial marker patients
could be treated with CyberKnife radiosurgery, and none
needed any additional fiducial marker placement.
The study group included 32 women and 20 men, with
a mean age of 73.8 years (range, 50–94 years). One patient
underwent fiducial marker placement twice, first with linear
and later successfully with coil fiducial markers. Seven pa-
tients had 2 tumor locations. Of the 60 lesions, 51 were
known non-small cell lung cancer or were discovered at
ENB by on-site biopsy assessment, 4 were proven metasta-
ses, and 5 were histologically unknown at ENB despite on-
site biopsy assessment. The mean tumor diameter was
23.7  10.2 mm (range, 8–53 mm). Of the 60 tumors, 35
(58%) were adjacent to the pleura. A total of 21 patients
(35%) underwent concurrent transbronchial biopsy at
ENB. The mean bronchoscopy procedure duration was
37  16.2 minutes (range, 15–70 minutes), and the mean
pulse-technique fluoroscopy time was 66  31 seconds
(range, 36–152 seconds).
Of the 52 patients, 3 developed pneumothorax (5.8%), 2
of which were associated with transbronchial biopsy. Two
of the patients were treated with pig-tail chest tube place-
ment in the bronchoscopy suite and one was observed.
A postprocedural survey was performed, and no additional
complications (eg, hemorrhage, pneumonia, hospital
admissions) were recorded. No procedure-related delays
in CyberKnife treatment were encountered.DISCUSSION
Many patients with early-stage lung cancer, because of
significant comorbidities such as COPD, severe cardiac-
related disease, or other disease, cannot undergo surgical re-
section. External beam radiotherapy has been used for many
of these medically inoperable patients, with cure rates ofgery c November 2010
FIGURE 1. Navigation of electromagnetic navigation bronchoscopy (ENB) sensor probe using multiplanar computed tomography (CT) images and
‘‘tip-view’’ orientation. Locator tip was 0.4 cm from center of targeted tumor location.
Schroeder et al Evolving Technology/Basic Scienceonly 15% to 35%.9,13,14 Stereotactic radiosurgery allows
for the delivery of high, potentially curative, doses of
focused radiation to such localized cancers. Tumor
motion in patients with lung cancer is a major obstacle to
stereotactic body radiosurgery. Multiple techniques,
including breath holding, abdominal compression, 4-
dimensional excursion prediction, and real-time tumor
tracking, are used to guide radiotherapy.15 The CyberKnife
with Synchrony technology uses real-time respiratory mo-
tion tracking with placement of dense metal (gold or plati-
num) fiducial markers in and near the tumor.16,17 Although,
in theory, real-time fiducial targeting might be more preciseFIGURE 2. A, Flattened platinum coil spring fiducial marker loaded in tip o
marker. B, Magnified diamond-shaped deployed coiled spring fiducial marker
The Journal of Thoracic and Carthan the nonfiducial-based targeting used by other systems,
their accuracy and effectiveness have, to date, not been
compared. Although all patients were able to receive com-
plete CyberKnife therapy without the need of any additional
fiducial markers, we cannot make any statements regarding
treatment efficacy because the median follow-up period was
just 9.3 months. Future reports are planned to determine the
clinical success and accuracy of this modality.
Typically, 3 noncoplanar fiducial markers are required,
each 2-cm apart.6,17 Early in the radiosurgery experience,
fiducial markers were placed using percutaneous CT
guidance. This required a number of passes, resulted inf microbiology specimen brush. Box insert: Deployed coil spring fiducial
with thrombogenic filament attachments.
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FIGURE 3. Radiopaque fiducial markers identified in and around right lung legion on A, postelectromagnetic navigation bronchoscopy (ENB) chest
radiograph, and B and C, corresponding computed tomography (CT) scan.
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a frequent need for pigtail chest tube placement.7-9
Patients with severe COPD have a very limited ability to
tolerate induced pneumothorax and could heal slowly,
requiring prolonged hospitalization. Using ENB, the
pneumothorax rate in our study was only 5.8%. Most of
our patients had COPD, and 7 had 2 tumors. All 3 tumors
were pleural-based and 2 had had simultaneous ENB trans-
bronchial biopsy specimens taken. Our pneumothorax rate
was within the expected published range of 2% to 6% for
ENB biopsy of peripheral lung lesions.11,12
The deployment of fiducial markers using CT guidance
has frequently been suboptimal. For more centrally located
tumors, this technique can be hazardous and is generally
avoided. Standard flexible fiberoptic bronchoscopy has
been used for fiducial placement in central lesions, but it
has obvious limitations for accessing peripheral tumors,
even with fluoroscopy.9 Furthermore, fiducial markers
placed with standard bronchoscopic techniques have had
a significant premature deployment or ‘‘drop’’ rate (22%)
owing to the absence of specialized tools and markers.18
The commonly used linear gold fiducial markers have
a very smooth surface and are frequently dislodged, usually
by coughing. Even with ENB techniques in very experi-
enced hands, linear fiducial markers become dislodged
10% to more than 20% of the time.10,11,18 In our first 4
patients, we lost more than 50% of the standard linear
gold fiducial markers. Therefore, we looked for fiducial
markers that would have better seating properties. We
have proposed the use of coil spring platinum markers,
which are commonly used in endovascular procedures.
Platinum is similar in density to the commonly used gold1140 The Journal of Thoracic and Cardiovascular Surfiducials and can be tracked using the CyberKnife system.
These fiducials expand after deployment into a diamond-
shaped structure and wedge themselves by recoil forces
into the surrounding lung tissue. Furthermore, dense polyes-
ter fibers attached to the metal coil promote thrombosis and
seating into the adjacent tissue. In the subsequent 56 proce-
dures, 217 fiducial markers were placed and only 2were dis-
lodged (<1%). Comparing the dislodgement rate of our coil
fiducials with that of linear-type fiducial markers reported
by Anantham and colleagues10 (4/39, 10%) and Harley
and colleagues11 (22/161, 13.6%), our coil fiducials were
significantly less likely to become dislodged (P ¼ .0056
and P¼ .0001, respectively) (Figure 4). All patients receiv-
ing coil fiducial markers were able to undergo radiosurgery
without placement of any additional fiducial markers.
ENB can be performed as an outpatient procedure with
the patient under moderate sedation. The procedure was
well tolerated, and the procedure time was within the
normal limits for interventional bronchoscopic proce-
dures.10,11,19-21 General anesthesia has been used at other
institutions and carries its own risks.11,12 The need for
anesthesia staff resources and the added associated costs
of general anesthesia favor the use of an interdisciplinary
bronchoscopy suite setting.
ENB-guided fiducial marker placement for CyberKnife
treatment of peripheral lung tumors is a safe and precise al-
ternative to transthoracic, intravascular, or bronchoscopic
modalities currently in use. The steering mechanism of
the locator tip and the visual 3-dimensional orientation al-
low ENB to navigate to a bronchoscopically invisible le-
sion, where the fiducial markers can be placed with
optimal spatial separation.gery c November 2010
FIGURE 4. Bar graph depicting remaining and dislodged fiducial markers
after electromagnetic navigation bronchoscopy (ENB). Coiled fiducial
markers (2 of 217) showed highly significant lower dislodgment rate com-
pared with linear fiducial markers compared with previous studies by
Anantham and colleagues10 and Harley and colleagues.11 P values calcu-
lated using Fisher’s exact test.
Schroeder et al Evolving Technology/Basic ScienceThe use of coil spring fiducial markers was 99% success-
ful for accurate and durable placement. From the published
studies, a fiducial loss rate of more than 10% has been com-
mon and results in a greater need of repeat placements and/or
a suboptimal CyberKnife tracking accuracy. The deployment
of coil spring fiducial markers using a common specimen
brush is easy to perform for any trained bronchoscopist.
The coil spring fiducial markers are more expensive (about
$104 vs $65) than the classic linear type. The lower dislodge-
ment rate should negate the need for repeat fiducial
placement10 and its attendant costs in materials, staff, and
periprocedural risk.E
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Dr Bryan Fitch Meyers (St. Louis, Mo). I see that there are ac-
tually several alternatives, and youmentioned some. You could use
percutaneous placement of these fiducials with a greater risk of
pneumothorax, but presumably that could be done with just a local
anesthetic. Your method has a pneumothorax risk as well, albeit
lower, but it would require more sedation or anesthetics, and peo-
ple would have to weigh the pros and cons of those different ap-
proaches. What was the sedation or anesthetic that you gave in
all or most of these patients, and could you just talk a little bit about
the setting of the procedure and the duration of the procedure?
Dr Schroeder. The maximum duration was up to 1 hour. We
got better with the learning curve. If it is just a straight fiducial
placement, we are down to a 20-minute procedure. It all depends
on whether you actually have an easy way to reach the tumor.
The patients are in moderate sedation in an out-patient setting.
We actually tap into the system of our pulmonology colleagues,
and fentanyl and midazolam is normally used.
I honestly think the lower rate of pneumothorax is worthwhile
to undergo a moderate sedation protocol. You see in some studies
every other patient has a pneumothorax with the treatment of a pig-
tail catheter and being in the hospital. I think that is an important
comorbidity.diovascular Surgery c Volume 140, Number 5 1141
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SDr Robert J. Cusimano (Toronto, Ontario, Canada). Just
a small question. I am a cardiac surgeon so I do not know about
these things. The coil markers, are they ferromagnetic? Can you
perform magnetic resonance imaging afterward?
Dr Schroeder.Yes, you can perform magnetic resonance imag-
ing. They stay in. They are platinum.
Dr Arjun Pennathur (Pittsburgh, Pa). Great presentation.
How many patients actually underwent biopsy that was proven?
It looked like on your last slide you said about 45%. So were other
55% still going to undergo transthoracic computed tomography
(CT)-guided biopsy? How did you perform biopsies on the rest
of the patients?1142 The Journal of Thoracic and Cardiovascular SurDr Schroeder. We are a secondary center, so we often have
people referred from the outside who had undergone bronchos-
copy or CT-guided biopsy beforehand.
Dr Pennarthur. How was your success rate for a peripheral
lesion with a navigational bronchoscopy to get a tissue
diagnosis?
Dr Schroeder. Our biopsy rate is about in the 50% range. I
know that in other hands with navigational bronchoscopy alone
it is in the 70% range. So, our rate was about 50%, unfortunately.
Dr Pennarthur. So, in those patients you would still perform
CT-guided biopsy?
Dr Schroeder. Or a repeat bronchoscopy is another possibility.gery c November 2010
